| Database ID | Agent | Target | Cancer Type | Detail |
| DB00316 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00317 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00318 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00319 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00320 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00321 | bortezomib, cetuximab | NA | head and neck cancer | view |
| DB00322 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00323 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00324 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00325 | cilengitide | ¦Áv¦Â3 and ¦Áv¦Â5 integrins | head and neck cancer | view |
| DB00326 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00327 | cetuximab | Epidermal growth factor receptor | esophageal cancer | view |
| DB00328 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |
| DB00329 | cetuximab | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00330 | cetuximab | Epidermal growth factor receptor | head and neck cancer | view |